Anchor Capital Advisors LLC trimmed its holdings in McKesson Co. (NYSE:MCK) by 1.4% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 148,416 shares of the company’s stock after selling 2,158 shares during the period. Anchor Capital Advisors LLC owned approximately 0.07% of McKesson worth $20,907,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of MCK. Boston Partners raised its stake in shares of McKesson by 122.4% in the first quarter. Boston Partners now owns 4,036,373 shares of the company’s stock valued at $568,604,000 after acquiring an additional 2,221,241 shares in the last quarter. Swedbank acquired a new stake in McKesson in the first quarter valued at $86,764,000. Kiltearn Partners LLP raised its stake in McKesson by 28.8% in the fourth quarter. Kiltearn Partners LLP now owns 1,802,098 shares of the company’s stock valued at $281,037,000 after buying an additional 402,566 shares in the last quarter. Amundi Pioneer Asset Management Inc. acquired a new stake in McKesson in the fourth quarter valued at $61,024,000. Finally, Schroder Investment Management Group raised its stake in McKesson by 80.1% in the fourth quarter. Schroder Investment Management Group now owns 822,506 shares of the company’s stock valued at $128,270,000 after buying an additional 365,699 shares in the last quarter. Institutional investors own 90.08% of the company’s stock.
In other McKesson news, SVP Erin M. Lampert sold 868 shares of the stock in a transaction that occurred on Wednesday, May 30th. The shares were sold at an average price of $142.00, for a total value of $123,256.00. Following the completion of the sale, the senior vice president now owns 64 shares in the company, valued at approximately $9,088. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.20% of the stock is owned by corporate insiders.
NYSE MCK traded up $0.48 on Thursday, hitting $150.00. The stock had a trading volume of 1,964,141 shares, compared to its average volume of 1,771,535. McKesson Co. has a one year low of $134.25 and a one year high of $178.86. The stock has a market cap of $29.34 billion, a price-to-earnings ratio of 11.89, a price-to-earnings-growth ratio of 1.34 and a beta of 1.26. The company has a current ratio of 1.01, a quick ratio of 0.57 and a debt-to-equity ratio of 0.67.
McKesson (NYSE:MCK) last released its earnings results on Thursday, May 24th. The company reported $3.49 EPS for the quarter, missing the consensus estimate of $3.56 by ($0.07). The business had revenue of $51.63 billion for the quarter, compared to analyst estimates of $51.36 billion. McKesson had a net margin of 0.03% and a return on equity of 23.55%. The firm’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same period in the prior year, the company earned $3.41 earnings per share. equities research analysts expect that McKesson Co. will post 13.33 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Monday, July 2nd. Investors of record on Friday, June 1st will be given a $0.34 dividend. The ex-dividend date is Thursday, May 31st. This represents a $1.36 annualized dividend and a dividend yield of 0.91%. McKesson’s dividend payout ratio (DPR) is presently 10.78%.
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.